Skip to content

Clinical trials

Phase 4 Asthma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Asthma Phase: Phase 4 Country / region: United States Clear all

150 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
200311
20048
20057
200610
200712
20085
20095
20107
20117
20125
201310
20143
20154
20167
20176
20186
20195
20204
20215
20225
20231
20248
20252
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed101
Terminated21
Recruiting9
Active, not recruiting8
Unknown status6
Withdrawn3
Not yet recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline25
AstraZeneca6
Teva Branded Pharmaceutical Products R&D, Inc.6
University of California, San Francisco5
University of Florida5
Novartis Pharmaceuticals4
Sanofi4
University of Texas Southwestern Medical Center4
California Allergy and Asthma Medical Group, Inc.3
Children's Hospital of Philadelphia3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Asthma150
Pulmonary Disease, Chronic Obstructive7
Rhinitis, Allergic6
Emergencies5
Pulmonary Eosinophilia4
Asthma, Exercise-Induced3
Lung Diseases3
Bronchial Spasm2
Dermatitis, Atopic2
Dyspnea2

Trials

Showing 1 to 25 of 150. Each trial links to its page on Pharma Observatory.

50 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.